- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Time factors
Total 40353 results
-
University Hospital HeidelbergGerman Cancer Research Center; National Center for Tumor Diseases, Heidelberg; German Cancer AidCompleted
-
Hoffmann-La RocheBreast International Group; Frontier Science & Technology Research Foundation... and other collaboratorsCompletedTriple Negative Breast CancerRussian Federation, United States, Israel, Italy, Spain, France, Korea, Republic of, United Kingdom, Denmark, Taiwan, Hungary, Argentina, Australia, Austria, Belgium, Brazil, China, Germany, Hong Kong, Japan, Mexico, Romania, Switze... and more
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerUnited States
-
Milton S. Hershey Medical CenterTerminatedAcute Myeloid LeukemiaUnited States
-
University of NebraskaNational Cancer Institute (NCI)Terminated
-
Fondazione Italiana Linfomi - ETSActive, not recruitingPeripheral T-cell Lymphomas (PTCL) | PTCL-NOS | Angioimmunoblastic T-cell Lymphoma (AITL) | ALK- Anaplastic Large Cell Lymphoma (ALCL) | Nodal Peripheral T-Cell Lymphoma of T Follicular Helper Cell OriginItaly
-
ImmunoVaccine Technologies, Inc. (IMV Inc.)TerminatedMaveropepimut-S (MVP-S) and Low-Dose CPA in Patients With Platinum-Resistant Ovarian Cancer (AVALON)Platinum-resistant Epithelial Ovarian CancerUnited States, Canada, Puerto Rico
-
Janssen Research & Development, LLCPharmacyclics LLC.CompletedLymphomaUnited States, France, Ukraine, United Kingdom, China, Germany, Spain, Argentina, Belgium, Israel, Russian Federation, Turkey, Japan, Australia, Sweden, Korea, Republic of, Brazil, Puerto Rico, Poland
-
University of NebraskaNational Cancer Institute (NCI)TerminatedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the ProstateUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers Squibb; National Cancer Institute (NCI); Aduro Biotech, Inc.CompletedPancreatic CancerUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingAnn Arbor Stage I Childhood Hodgkin Lymphoma | Ann Arbor Stage II Childhood Hodgkin Lymphoma | Childhood Nodular Lymphocyte Predominant B-Cell LymphomaUnited States, Canada, Australia, New Zealand, Puerto Rico, Israel
-
Roswell Park Cancer InstituteNational Center for Advancing Translational Sciences (NCATS)CompletedAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Prognostic Stage I Breast Cancer AJCC v8 | Prognostic... and other conditionsUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Juno Therapeutics, Inc.CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
St. Jude Children's Research HospitalActive, not recruiting
-
European Myeloma NetworkFondazione EMN Italy OnlusCompletedMultiple MyelomaNetherlands, Italy
-
University of NebraskaNational Cancer Institute (NCI)Completed
-
European Myeloma NetworkEMN Research ItalyActive, not recruitingMultiple MyelomaCzechia, Greece, Italy
-
University of Southern CaliforniaNational Cancer Institute (NCI); Brooklyn ImmunoTherapeutics, LLCActive, not recruitingCervical Squamous Cell Carcinoma In Situ | Vulvar High Grade Squamous Intraepithelial LesionUnited States
-
University of NebraskaNational Cancer Institute (NCI)TerminatedRecurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent... and other conditionsUnited States
-
Kite, A Gilead CompanyCompletedRelapsed Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B Cell Lymphoma (DLBCL) | Transformed Follicular Lymphoma (TFL) | Primary Mediastinal B-cell Lymphoma (PMBCL) | High Grade B-cell Lymphoma (HGBCL)United States, Netherlands, Canada, France, Germany, Israel
-
Chipscreen Biosciences, Ltd.Active, not recruitingDiffuse Large B-cell LymphomaChina
-
University of Colorado, DenverBristol-Myers SquibbActive, not recruitingPeripheral T Cell LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterStanford University; Juno Therapeutics, Inc.Active, not recruiting
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingLocalized Extraskeletal Ewing Sarcoma | Peripheral Primitive Neuroectodermal Tumor of Bone | Peripheral Primitive Neuroectodermal Tumor of Soft TissuesUnited States, Canada, Saudi Arabia, Australia, New Zealand, Puerto Rico
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedMetastatic Melanoma | Stage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7United States
-
Celyad Oncology SAActive, not recruitingRelapse/Refractory Multiple MyelomaBelgium, United States
-
St. Jude Children's Research HospitalActive, not recruitingB-ALL | T-ALL | AML/MDS | BPDCNUnited States
-
Canadian Cancer Trials GroupAmgen; Canadian Myeloma Research GroupCompleted
-
Kite, A Gilead CompanyTerminated
-
Peter MacCallum Cancer Centre, AustraliaHoffmann-La RocheActive, not recruitingDiffuse Large B Cell Lymphoma | High-grade B-cell LymphomaAustralia
-
St. Jude Children's Research HospitalActive, not recruitingAcute Lymphoblastic Leukemia, in Relapse | Acute Lymphoblastic Leukemia, RefractoryUnited States
-
Canadian Cancer Trials GroupOncolytics BiotechCompleted
-
CelgeneCompletedMultiple MyelomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI); Novartis; Lymphoma Research FoundationCompleted
-
Icahn School of Medicine at Mount SinaiTerminatedLocally Advanced Breast CancerUnited States
-
Andrew Yee, MDBristol-Myers Squibb; Takeda Pharmaceuticals North America, Inc.TerminatedRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
Tceleron Therapeutics, Inc.TerminatedMetastatic Castration-resistant Prostate CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnProgressive Disease | Recurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Refractory Chronic Lymphocytic Leukemia | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Minimal Residual Disease | Recurrent Chronic Lymphocytic Leukemia | CD19 Positive | CD22...United States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLymphoma | LeukemiaUnited States
-
University of ArkansasActive, not recruitingMyelomaUnited States
-
St. Jude Children's Research HospitalActive, not recruitingAplastic Anemia | Bone Marrow Failure SyndromeUnited States
-
ChemoCentryxCompletedANCA-associated VasculitisUnited States, Canada
-
Memorial Sloan Kettering Cancer CenterDana-Farber Cancer Institute:Dana- Farber/Children's HospitalActive, not recruitingRelapsed B-Cell Acute Lymphoblastic LeukemiaUnited States
-
National Cancer Institute (NCI)Active, not recruitingLymphoma, Large B-Cell, Diffuse | Lymphoma, AIDS-relatedUnited States
-
Roswell Park Cancer InstituteNational Comprehensive Cancer NetworkActive, not recruitingMetastatic Colon Adenocarcinoma | Metastatic Rectal Adenocarcinoma | Stage III Colon Cancer AJCC v8 | Stage III Rectal Cancer AJCC v8 | Stage IIIA Colon Cancer AJCC v8 | Stage IIIB Rectal Cancer AJCC v8 | Stage IIIC Colon Cancer AJCC v8 | Stage IV Colon Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC... and other conditionsUnited States
-
Allogene TherapeuticsActive, not recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
Allogene TherapeuticsActive, not recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
University of ArkansasMillennium Pharmaceuticals, Inc.Active, not recruitingMultiple MyelomaUnited States
-
University of ArkansasActive, not recruitingUARK 2008-02 A Trial for High-risk Myeloma Evaluating Accelerating and Sustaining Complete RemissionMultiple MyelomaUnited States
-
Shanghai Henlius BiotechActive, not recruiting